These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 1695626)
1. Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity. Clemmons DR; Cascieri MA; Camacho-Hubner C; McCusker RH; Bayne ML J Biol Chem; 1990 Jul; 265(21):12210-6. PubMed ID: 1695626 [TBL] [Abstract][Full Text] [Related]
2. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. Bayne ML; Applebaum J; Chicchi GG; Miller RE; Cascieri MA J Biol Chem; 1990 Sep; 265(26):15648-52. PubMed ID: 2168421 [TBL] [Abstract][Full Text] [Related]
3. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs. Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166 [TBL] [Abstract][Full Text] [Related]
4. The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor. Bayne ML; Applebaum J; Underwood D; Chicchi GG; Green BG; Hayes NS; Cascieri MA J Biol Chem; 1989 Jul; 264(19):11004-8. PubMed ID: 2472386 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Ritvos O; Ranta T; Jalkanen J; Suikkari AM; Voutilainen R; Bohn H; Rutanen EM Endocrinology; 1988 May; 122(5):2150-7. PubMed ID: 2452077 [TBL] [Abstract][Full Text] [Related]
6. Structural analogs of human insulin-like growth factor (IGF) I with altered affinity for type 2 IGF receptors. Cascieri MA; Chicchi GG; Applebaum J; Green BG; Hayes NS; Bayne ML J Biol Chem; 1989 Feb; 264(4):2199-202. PubMed ID: 2536701 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor 1 (IGF-1). Carlsson-Skwirut C; Lake M; Hartmanis M; Hall K; Sara VR Biochim Biophys Acta; 1989 May; 1011(2-3):192-7. PubMed ID: 2469478 [TBL] [Abstract][Full Text] [Related]
8. Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media. De Vroede MA; Tseng LY; Katsoyannis PG; Nissley SP; Rechler MM J Clin Invest; 1986 Feb; 77(2):602-13. PubMed ID: 2418066 [TBL] [Abstract][Full Text] [Related]
9. Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor. Bayne ML; Applebaum J; Chicchi GG; Hayes NS; Green BG; Cascieri MA J Biol Chem; 1988 May; 263(13):6233-9. PubMed ID: 2966152 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: immunological relationship to other human IGF-BPs. Martin JL; Baxter RC Endocrinology; 1988 Oct; 123(4):1907-15. PubMed ID: 2970958 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979 [TBL] [Abstract][Full Text] [Related]
12. Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies. Jansen J; van Buul-Offers SC; Hoogerbrugge CM; Van Den Brande JL Biochem J; 1990 Mar; 266(2):513-20. PubMed ID: 2156497 [TBL] [Abstract][Full Text] [Related]
13. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Ernst M; Rodan GA Endocrinology; 1990 Aug; 127(2):807-14. PubMed ID: 2164921 [TBL] [Abstract][Full Text] [Related]
14. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. King GL; Goodman AD; Buzney S; Moses A; Kahn CR J Clin Invest; 1985 Mar; 75(3):1028-36. PubMed ID: 2984251 [TBL] [Abstract][Full Text] [Related]
15. Intrinsic bioactivity of insulin-like growth factor-binding proteins from vascular endothelial cells. Booth BA; Bar RS; Boes M; Dake BL; Bayne M; Cascieri M Endocrinology; 1990 Dec; 127(6):2630-8. PubMed ID: 2174333 [TBL] [Abstract][Full Text] [Related]
16. Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule. Oh Y; Beukers MW; Pham HM; Smanik PA; Smith MC; Rosenfeld RG Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):249-54. PubMed ID: 1715685 [TBL] [Abstract][Full Text] [Related]
17. Interaction of insulin-like growth factor I with porcine thyroid cells cultured in monolayer. Saji M; Tsushima T; Isozaki O; Murakami H; Ohba Y; Sato K; Arai M; Mariko A; Shizume K Endocrinology; 1987 Aug; 121(2):749-56. PubMed ID: 3036481 [TBL] [Abstract][Full Text] [Related]
19. Characterization of insulin-like growth factor-binding proteins in cultured rat pituitary cells. Rosenfeld RG; Pham H; Oh Y; Ocrant I Endocrinology; 1989 Jun; 124(6):2867-74. PubMed ID: 2542002 [TBL] [Abstract][Full Text] [Related]
20. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. Francis GL; Ross M; Ballard FJ; Milner SJ; Senn C; McNeil KA; Wallace JC; King R; Wells JR J Mol Endocrinol; 1992 Jun; 8(3):213-23. PubMed ID: 1378742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]